Start » Department of Cardiovascular Surgery » Catheter-based valve treatment » Catheter-based mitral valve replacement

Catheter-based implantation of a mitral valve prosthesis – TMVI

Both patients with mitral valve regurgitation (leakage), mitral valve stenosis (narrowing) or patients after biological mitral valve replacement with degeneration, i.e. narrowed or leaking prosthesis, can be offered catheter-based treatment procedures. Patients with mitral valve disease usually experience shortness of breath and a reduction in their physical performance.

For patients identified by the HEART team as being at increased surgical risk, the feasibility of a minimally invasive therapeutic procedure, i.e. catheter-based implantation of a mitral valve prosthesis (TMVI), can be assessed.

To check the feasibility of TMVI surgery, a computer tomography (CT) scan of the mitral valve and surrounding heart structures is performed, along with other tests. The CT scan measures the size of the mitral valve and shows its positional relationship to the surrounding heart structures. This information is needed to determine valve models and valve sizes.

Two hybrid operating theatres are available for TMVI procedures. The procedures are performed under general anaesthesia and echocardiographic (TOE; ultrasound through the oesophagus) and fluoroscopic (X-ray fluoroscopy) control. The mitral valve is accessed either through the inguinal vessels and then through the atrial septum or from the apex of the heart. Various prosthetic heart valves are available to treat either diseases of previously untreated mitral valves or biological mitral valve prostheses that are exhibiting signs of degeneration.